NDC 0015-3404

ETOPOPHOS

Etoposide Phosphate

ETOPOPHOS is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Etoposide Phosphate.

Product ID0015-3404_23c5d977-f8be-4f5b-b810-9a0ec0866925
NDC0015-3404
Product TypeHuman Prescription Drug
Proprietary NameETOPOPHOS
Generic NameEtoposide Phosphate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2009-06-01
Marketing CategoryNDA / NDA
Application NumberNDA020457
Labeler NameE.R. Squibb & Sons, L.L.C.
Substance NameETOPOSIDE PHOSPHATE
Active Ingredient Strength100 mg/1
Pharm ClassesTopoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0015-3404-20

1 VIAL, SINGLE-DOSE in 1 CARTON (0015-3404-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Marketing Start Date2009-06-01
Marketing End Date2021-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0015-3404-20 [00015340420]

ETOPOPHOS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA020457
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-06-01
Marketing End Date2021-04-30

Drug Details

Active Ingredients

IngredientStrength
ETOPOSIDE PHOSPHATE100 mg/1

Pharmacological Class

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

NDC Crossover Matching brand name "ETOPOPHOS" or generic name "Etoposide Phosphate"

NDCBrand NameGeneric Name
0015-3404ETOPOPHOSetoposide phosphate
61269-410ETOPOPHOSetoposide phosphate

Trademark Results [ETOPOPHOS]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ETOPOPHOS
ETOPOPHOS
74179774 1757537 Live/Registered
CHEPLAPHARM ARZNEIMITTEL GMBH
1991-06-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.